For 30 years the Deep Sea Drilling Project (DSDP) and the Ocean Drilling Program (ODP) have been drilling the ocean floors and retrieving sediment cores. This study presents a relational micropaleontological and stratigraphic database, Neptune, where a selection of the published studies made on these sediments is available. The selected sites and their stratigraphic extent represent a statistically reproducible subset of the whole DSDP and ODP data set as of 1995 (up to Leg 135). Cenozoic sediments from 165 globally distributed holes were dated with age/depth plots using biochronology of four marine plankton groups (diatoms, nannofossils, foraminifera, and radiolarians). Each hole’s location is available with paleogeographic coordinates. A taxonomic revision of the 8000+ reported species names was also made. The database is searchable and a variety of routines are available. Data can be exported to produce age range charts, geographic distribution maps, and occurrence charts. A rigorous evaluation of the database potentials and limitations is presented together with a summary of the published studies that have been carried on with the data. These include stratigraphic studies (diachrony of Neogene plankton, hiati distribution in Cenozoic sediments) and evolution studies (cladogenesis and evolution of one foraminiferal lineage). Unpublished data on macroevolutionary patterns (species longevity and richness, speciation and extinction rates) are presented as example of Neptune’s potential for paleobiological research. Finally, some suggestions are presented as to how Neptune can be more fully exploited through the addition of sedimentologic and isotopic data. A variety of critical sedimentologic and paleoceanographic questions could be addressed with this extended database.

/pdf/the-cenozoic-deep-sea-microfossil-record-explorations-of-the-h3gjhyriuq.pdf

The cenozoic deep sea microfossil record: explorations of the dsdp/odp sample set using the neptune database

Planktonic foraminiferal biostratigraphy and mechanisms in the extinction of Morozovella in the late middle Eocene

Cenozoic Southern Ocean Reconstructions from Sedimentologic, Radiolarian, and other Microfossil Data

Ocean Drilling Program Hole 803D (Leg 130) from the western tropical Pacific (Ontong Java Plateau) and Hole 628A (Leg 101) from the western subtropical North Atlantic (Little Bahama Bank) contain rich assemblages of planktonic foraminifers. The uppermost Eocene-basal Miocene section of Hole 803D is apparently complete, whereas the Oligocene section of Hole 628A contains three unconformities based on planktonic foraminiferal evidence. Anomalous ranges are recorded for Chiloguembelina cubensis and Globigerinoides primordius. C. cubensis is found to range throughout the upper Oligocene of both sites, and G. primordius first occurs near the base of upper Oligocene Zone P22 in Hole 628A. Paleomagnetic stratigraphy provides constraints on the last occurrence (LO) of Subbotina angiporoides, the first occurrence (FO) of Globigerina angulisuturalis, the FO of Globigerinoides primordius, the FO of Paragloborotalia pseudokugleri, and the LO of Chiloguembelina cubensis. In general, taxon ranges, total diversity, and the composition of the planktonic foraminiferal assemblages from Holes 628A and 803D are similar. Differences in the composition of planktonic foraminiferal assemblages between the two sites are interpreted to be primarily the result of enhanced dissolution at Site 803 (e.g., paucity of Globigerina angulisuturalis and absence of G. ciperoensis). However, the greater abundances of Subbotina angiporoides in subtropical Hole 628A and Paragloborotalia opima in tropical Hole 803D are probably related to oceanographic differences between the two low-latitude sites. Comparison between the low and southern high latitudes illustrates some similarities in the composition of Oligocene planktonic foraminiferal assemblages as well as some important differences. Species such as Pseudohastigerina spp., Turborotalia increbescens, "Turborotalia" ampliapertura, Paragloborotalia opima, P. pseudokugleri, P. semivera/mayeri, Globigerinella obesa, Globigerina angulisuturalis, G. gortanii, G. ouachitaensis, G. sellii, G. tapuriensis, G. tripartita, G. pseudovenezuelana, Subbotina? eocaena and 5.? yeguaensis are absent or have rare occurrences in the subantarctic Oligocene assemblages. Biogeographic gradients, although not as pronounced as during the late Neogene, were nonetheless significant during the Oligocene.

/pdf/oligocene-planktonic-foraminifer-biostratigraphy-of-hole-48hfxammbl.pdf

Oligocene Planktonic Foraminifer Biostratigraphy of Hole 803D (Ontong Java Plateau) and Hole 628A (Little Bahama Bank), and Comparison with the Southern High Latitudes

A major revision to the Antarctic Paleogene planktonic foraminifer biozonation is presented using the latest species concepts and biostratigraphic studies of Ocean Drilling Program (ODP) sites located between 52°S and 65°S paleolatitude in the southern South Atlantic and southern Indian Oceans. Shorthand prefixes for the Antarctic Paleogene zones are designated as “AP” zones for the “Antarctic Paleocene”, “AE” zones for the “Antarctic Eocene”, and “AO” zones for the “Antarctic Oligocene”. New numerical ages for Paleogene planktonic foraminiferal and calcareous nannofossil first- and last-occurrence events are estimated using new age-depth curves constructed for ODP Sites 738 and 744 in the southern Indian Ocean. The order and timing of these events are compared with bio-, magneto- and chemostratigraphic datums that have been recently published, reinterpreted, or observed in the present study. The revised zonal framework and age models will improve correlation of Paleogene planktonic foraminifer pelagic and hemipelagic carbonate sequences within and outside the Austral Realm.

Revised paleogene planktonic foraminiferal biozonation for the austral realm

/pdf/planktonic-foraminiferal-biostratigraphy-and-2llhfeaeaa.pdf

Planktonic Foraminiferal Biostratigraphy and Paleoenvironmental Interpretation of Paleogene Faunas from the Subantarctic Transect, Leg 114

BACKGROUND
The Covid 19 pandemic might have impacted response to drug treatment in major depressive episode (MDE). We compared responses to three different antidepressant drugs, i.e., vortioxetine, sertraline, and trazodone, in outpatients with MDE during Major Depressive Disorder (MDD), Bipolar Disorder (BD), or schizophrenia and related psychoses (SSOPDs) during two time periods, i.e., prior to suffering Covid-19-related trauma and after suffering such trauma.


METHODS
We conducted an observational study on clinically stabilised for at least 6 months outpatients with MDE during the course of MDD (N=58), BD (N=33), or SSOPDs (N=51). Patients, whose baseline assessments of Montgomery-Åsberg Rating Scale (MADRS), Hamilton Anxiety Rating Scale (Ham-A), Brief Psychiatric Rating Scale (BPRS), Visual Analogue Scale for Craving (VAS-crav) and World Health Organization Quality of Life, Brief version (WHOQOL-BREF) were available, were recruited at the time they suffered Covid-19-related traumas. Fifty patients, prior to the pandemic, when they were clinically stable, were treated with 15 mg/die vortioxetine, 44 with 450 mg/die trazodone, and 48 with 150 mg/die sertraline. After experiencing a major Covid-19-related personal trauma, patients showed clinical worsening which required dosage adjustment (20 mg/day vortioxetine; 600 mg/day trazodone, and 200 mg/day sertraline) and, for a part of them, a month of hospitalisation. Scores on the MADRS, Ham-A, BPRS, VAS-crav and WHOQOL-BREF were compared drug-wise and gender-wise with Student's t test for continuous variables and χ2 for categorical variables.


RESULTS
The sample consisted of 142 outpatients (age, mean 39.63 ± 16.84; 70 men and 72 women); women were older than men (mean age 43.18 ± 17.61 vs. 35.98 ± 15.30; p=0.01). The two genders did not differ on other variables). For all treatments, symptoms worsening was observed at the time of trauma, followed by slow recovery with treatment readjustment. Trauma-related worsening in patients on vortioxetine was less intense than patients on the other two antidepressants and recovery was faster. All drugs were associated with an improvement in QoL. The vortioxetine group showed a lower hospitalisation rate (24%) than sertraline (35.4%) and trazodone (38.6%), but this was not significant (p=0.27).


CONCLUSION
All drugs improved symptoms after Covid-19 trauma in patients with MDE, with vortioxetine showing a small advantage. No differences between vortioxetine, sertraline and trazodone were found as concerns the need for hospitalisation.

Differential response to three antidepressants in patients with major depressive episode who suffered Covid-19-related trauma.

Partial dopamine D2 receptor agonists are used for psychotic symptoms in adults with schizophrenia spectrum disorders. Recently, interest surged for partial dopamine D2 receptor agonists in substance use disorders (SUDs). Since it is believed that SUDs decrease the efficacy of pharmacotherapy of underlying psychiatric disorders, we tested the efficacy of the partial D2 agonist brexpiprazole in patients with schizophrenia who were either comorbid with a SUD (SUD group) or not comorbid (non-SUD) to assess treatment response and the effect of brexpiprazole on substance craving in SUD.We included patients with DSM-5/DSM-5-TR schizophrenia (using SCID-5-CV) aged 18–66 years with either comorbid SUD or non-SUD to treat with brexpiprazole 4 mg/day for 6 months during February–October 2022. Patients were assessed with the Clinical Global Impressions–Severity (CGI-S) scale, the 24-item Brief Psychiatric Rating Scale (BPRS), and the Positive And Negative Syndrome Scale (PANSS) at baseline, weekly for the first 2 months and monthly for the next four. Furthermore, we assessed substance craving in SUD with a visual analog scale for craving (VAScrav) at the same timepoints.The total sample was 86 (85 analysable) 18- to 64-year-old (mean 39.32 ± 14.09) patients with schizophrenia [51 men (59.3%) and 35 women (40.7%)], of whom 48 SUD (55.8%) (37 men and 11 women) and 38 non-SUD (44.2%) (14 men and 24 women). No serious or persistent adverse events developed over the study period, but one patient dropped out for subjective akathisia. Results indicated the main effects of time with improvements over the course of the study for CGI-S, BPRS, and PANSS in both SUD and non-SUD groups and the entire sample, and for VAScrav in SUD. Brexpiprazole was associated with similar significant improvements in both groups at the 6 month endpoint compared to baseline.Treatment with brexpiprazole for 6 months improved psychotic symptoms in patients with schizophrenia, independently from whether they belonged to the SUD or the non-SUD group; hence, SUD comorbidity did not confer treatment resistance to brexpiprazole. Furthermore, in the SUD group, we observed reduced substance craving.

Brexpiprazole in patients with schizophrenia with or without substance use disorder: an observational study

Abstract Background Adverse childhood experiences (ACEs), social–emotional impairments (SEIs), and neurodevelopmental disorders (NDs) are frequent in psychiatric disorders, including substance-use disorders. We aimed to determine the prevalence of ACE, SEI, or ND in individuals with cannabis-use disorder (CUD). We compared individuals with preCUD-onset ACE, SEI, or ND to those without. Methods We crosssectionally studied 323 inpatients or outpatients with a history of past or current CUD, aged 12–35 years (mean age 22.94 ± 4.79), 64.5% of whom were male. The sample was divided into two groups: the non-premorbid (N = 52) and the premorbid ACE/SEI/ND group (N = 271). Within the premorbid group, further subgroups were based on ACEs, SEI, and NDs. We also analyzed other substance use and psychiatric symptoms/diagnoses based on the non-premorbid-premorbid dichotomy in the CUD sample. Results Pre-CUD ACE-SEI-ND had higher prevalence of bipolar, schizoaffective, borderline personality, and attention-deficit/hyperactivity disorders, and a history of agitation, hallucinations, and self-injury. The ACE group had higher rates of agitation, depression, delusions, hallucinations, eating disorders, and use of cocaine, amphetamines, and hallucinogens than the SEI or ND. Patients in the premorbid group initiated cannabis use at an earlier age, experienced the first comorbid psychiatric episode earlier, and were hospitalized earlier than those in the non- premorbid ACE-SEI-ND group. Conclusions PreCUD-onset ACE, SEI, or ND conditions in individuals with CUDare linked to earlier onset of comorbid mental illness. Furthermore, ACEs contribute to significant and potentially severe clinical symptoms, as well as the use of substances other than cannabis.

A Comprehensive Evaluation of Adverse Childhood Experiences, Social-Emotional Impairments, and Neurodevelopmental Disorders in Cannabis Use Disorder: Implications for Clinical Practice.

Transition to psychotic disorder: premorbid early-onset psychosis comorbid with cannabis use disorder

Handle everyday research tasks with reliable, citation-backed results

Your personal Research Agent to handle research tasks with citation-backed results

Popular Tasks used by Researchers

How can I help with your research?

Meet SciSpace

Get more enhanced response by uploading the PDFs you want me to reference.

No relevant PDFs in your library

SciSpace is the AI research assistant for academics. Run systematic literature reviews on 280M+ papers, and write papers with cited sources. Trusted by 1M+ students, PhDs & researchers.

SciSpace | AI for Research

Analyze PDFs

Code & Manuscripts

Funding & Grants

Literature & Patents

Medical & Clinical Data

Systematic Review

Visualize & Present

Web & Data

Build a Google Scholar-like website for your research.

Build a website

Create charts and images for your research

Create a Chart

Write a paper for submission to a journal

Draft a manuscript

Patent Search

Design eye-catching scientific posters in minutes.

Scientific Poster Generation

Systematic Literature Review

One task is running at the moment. Your messages will be shown right after.

Drag and drop or click here to browse

Loved by <highlight>1 million+</highlight> researchers

Extract a list of specific topics and their sources from unstructured text

Topics

Compare and analyze relevant papers that matches with your search

Papers

Get insights from PDFs and bookmarked papers from your library

My library

Recent searches

Try searching for:

Catch AI-generated content in scholarly and non-scholarly content

{ai} Detector

Ai Writer

Get PDF Summaries, highlighted text explanations 

Chat with PDF

Effortlessly create in-text citations and bibliographies in APA and 2,500 other formats

Citation generator

Get explanations, summaries, and answers on academic papers

Ease up your research workflow with {scispace}'s cohort of exciting AI tools

Elevate your academic writing skills and convey your ideas the way you want

Paraphraser

Explore our range of reading and writing tools

Your file is being prepared and should be ready in a few minutes. If it's a large file, it might take a bit longer. You can close this window, and we'll email you the file when it's done.

You have reached a maximum limit of <strong>{limit}</strong> columns in the table. Remove at least <strong>1</strong> column to add or create another one.

E. Amici

Author Tools

Chat about Author